BSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.
Alkem Laboratories Ltd: key numbers
- Share price
- ₹5,297.00
- Market cap
- ₹63,334 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 29.4×Sector 43.0×
- Promoter holding
- 49.70%+0.00% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkem Laboratories Ltd
All →Alkem Laboratories Board Meeting Date
Alkem Laboratories has scheduled its Board meeting for 12 Nov 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
Alkem Laboratories Management Change
Alkem Laboratories appointed Dr. Amrut Naik as CEO effective November 11, 2026. The Board designated him as Key Managerial Personnel at its November 3 meeting.
Alkem Laboratories Business Update
Alkem informed the exchange that US FDA completed inspection of its Mandva API facility with no Form 483 observations. The clean result confirms regulatory compliance.
Alkem Laboratories Legal & Regulatory
Alkem Laboratories has initiated a forensic audit by Grant Thornton Bharat LLP following alleged misappropriation of funds by a former employee.
Alkem Laboratories Other Announcement
Alkem Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This document details the company's equity structure.
Alkem Laboratories Management Change
Alkem Laboratories appointed Laxmikant Tiwari and Nilesh Vartak as Senior Management Personnel effective 12 October 2026. The appointments strengthen pharmaceutical operations and supply chain leadership.
Other capital structure change announcements
All →Tata Steel Capital Structure Change
Tata Steel's stake in subsidiary CPDPL rose from 51% to 57.5% via conversion of preference shares. CPDPL remains a subsidiary; no fresh capital was subscribed.
Filatex India Capital Structure Change
Filatex India invested Rs.13.00 Crore by subscribing 1.30 crore rights shares of wholly owned subsidiary Ecosis at Rs.10. Funds support the polyester recycling project, loan repayment and working capital.
- Value
- ₹13.00 Cr
Zydus Lifesciences Capital Structure Change
LIC sold 20,242,068 Zydus Lifesciences shares via market sale, cutting its stake from 5.21 percent to 3.18 percent. Non-promoter SAST disclosure covering 28.08.2025 to 05.11.2026.
Indian Oil Corporation Capital Structure Change
LIC, a non-promoter shareholder, reported a market sale of 28,34,86,368 shares in Indian Oil, cutting its holding from 7.887% to 5.879%. No monetary value is stated.
- Promoter stake change
- -2.01%
Kirloskar Oil Engines Capital Structure Change
Kirloskar Oil Engines signed a shareholders' agreement with TPG for its subsidiary Arka Fincap. TPG's investment totals ₹800 Crore across two tranches, the second conditional.
- Value
- ₹800.0 Cr
Ace Software Exports Ltd Partly Paidup Capital Structure Change
Ace Software Exports approved a ₹30.25 second and final call on 54,71,101 partly paid shares. The record date is 20 November 2026.
- Value
- ₹16.55 Cr